Strategic Consulting Services

Scientific Insight That Moves Programs Forward

As a science-first preclinical CRO, TSRLabs provides strategic consulting services that help biotech and pharmaceutical teams navigate complex development challenges. Our scientists partner with sponsors to define the right studies, interpret results with clarity, and build a smarter path from discovery through IND readiness.

Guidance for Every Stage of Development

We serve as an extension of your team, meeting you where you are and supporting where you’re going. Whether you’re building an early program or reassessing a stalled candidate, our consulting services help you make informed decisions earlier, avoid costly missteps, and bring structure, focus, and momentum to your development plan.

  • Early-stage development planning

  • Compound profiling and study prioritization

  • Dosing regimen development and formulation strategy

  • Translational input to guide preclinical design

  • Assessment of data gaps and study refinement

  • Non-dilutive funding guidance and academic collaboration planning

Why Choose TSRLabs for Strategic Consulting?

TSRLabs delivers guidance that connects the science to your goals and helps your team move forward with confidence.

Deep Subject Matter Expertise

With decades of experience in drug delivery, PK/ADME, and formulation at large pharma

Hands-On Support

Grounded in scientific rigor and practical execution

Flexible Engagement Options

Including one-time strategy sessions or ongoing program guidance

In-House Services Integration

So recommendations can move directly into action

Clients are Saying

Having a resource like TSR Labs in Ann Arbor is vital to the overall life sciences innovation ecosystem. Early-stage biotech entrepreneurs can benefit tremendously from the types of services that TSR Labs provides, from preclinical study design, to drug development consultation and even partnered accelerator support. Their team of drug development experts are there to help their clients create a roadmap to success.
Connie Chang, MBA, Chief Operating Officer
ONL Therapeutics, Inc.

Let's Talk About Your Program

Connect with a TSRLabs scientist to learn how we can support your goals with strategic, science-driven solutions by filling out this form.